Skip to Content

Celemics Inc Ordinary Shares 331920

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

331920 is trading at a 55% discount.
Price
KRW 3,618.06
Fair Value
KRW 9,558.47
Uncertainty
Extreme
1-Star Price
KRW 52,661.13
5-Star Price
KRW 185.72
Economic Moat
Yfqw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 331920 is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
KRW 3,580.003,655.00
52-Week Range
Bid/Ask
KRW 3,635.00 / KRW 3,645.00
Market Cap
KRW 29.76 Bil
Volume/Avg
4,497 / 47,586

Key Statistics

Price/Earnings (Normalized)
Price/Sales
4.65
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Celemics Inc is a manufacturer of Next Generation Sequencing test kit. It offers, develops and manufactures proprietary DNA and genetic sequencing test kits and panels. Its products include Targeted Sequencing Kit, NGS Library Preparation Kit, and XSEP MagBead.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
67

Valuation

Metric
331920
Price/Earnings (Normalized)
Price/Book Value
1.93
Price/Sales
4.65
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
331920
Quick Ratio
6.95
Current Ratio
7.71
Interest Coverage
−111.49
Quick Ratio
331920

Profitability

Metric
331920
Return on Assets (Normalized)
−26.87%
Return on Equity (Normalized)
−31.62%
Return on Invested Capital (Normalized)
−32.88%
Return on Assets
331920
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesBpndtjssNbtnrw$185.4 Bil
SYK
Stryker CorpPmpyrhrmBrj$128.2 Bil
BSX
Boston Scientific CorpLdhpfbvzvVzpgly$107.7 Bil
MDT
Medtronic PLCPrvwqpmlFpgxls$105.2 Bil
DXCM
DexCom IncFkzfzqpmcwGdrmm$54.7 Bil
EW
Edwards Lifesciences CorpXfdywmnfqMdfvtpb$52.8 Bil
ZBH
Zimmer Biomet Holdings IncCnhdqjhwsdYxw$24.6 Bil
ALGN
Align Technology IncQlsxfvgMrnkvs$23.4 Bil
PHG
Koninklijke Philips NV ADRQprwnlqrCcvsjys$18.7 Bil
PODD
Insulet CorpBbxtcpcqXhdbz$11.5 Bil

Sponsor Center